Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 1, 2003
Making use of the primary tumourArnold Baars, Jan Buter, Herbert M Pinedo
Neoplasia (New York, N.Y.)|January 15, 2010
Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patientsJeanine M Roodhart, Marlies H Langenberg, Joost S Vermaat, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2019
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trialBas D Koster, Saskia J A M Santegoets, Jorien Harting, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2019
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trialBas D Koster, Saskia J A M Santegoets, Jorien Harting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2007
Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patientsBarbara G Molenkamp, Paul A M van Leeuwen, Sybren Meijer, et al.
Palliative Medicine|November 14, 2025
Sexual health at the end of life in patients with advanced cancer and their partners. Results of a Dutch prospective longitudinal study (eQuiPe)Isabel S van der Meer, Moyke A J Versluis, Heidi P Fransen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanomaInge S van Houdt, Joost J Oudejans, Alfonsus J M van den Eertwegh, et al.
Clinical and Experimental Medicine|April 7, 2023
Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancerJanine Ziemons, Romy Aarnoutse, Anne Heuft, et al.
Clinical Colorectal Cancer|November 21, 2021
The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With CapecitabineRomy Aarnoutse, Janine Ziemons, Judith de Vos-Geelen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II TrialsBas D Koster, Mari F C M van den Hout, Berbel J R Sluijter, et al.
Pageof 3